UB Paderborn / Katalog / Suche / in CDI

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.615-621

2012

Link zum Volltext

Verfügbarkeit prüfen

Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (s4), p.71-75

2014

Link zum Volltext

Verfügbarkeit prüfen

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

Haematologica (Roma), 2008-02, Vol.93 (2), p.232-239

2008

Link zum Volltext

Verfügbarkeit prüfen

Measurement and prevalence of circulating ADAMTS13‐specific immune complexes in autoimmune thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2014-03, Vol.12 (3), p.329-336

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2356-2367

2016

Link zum Volltext

Verfügbarkeit prüfen

Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand

Thrombosis and haemostasis, 2014-04, Vol.111 (4), p.656

2014

Link zum Volltext

Verfügbarkeit prüfen

Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.697-703

2013

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol homeostasis is dysregulated in women with preeclampsia

Polskie archiwum medycyny wewne̦trznej, 2021-12, Vol.131 (12)

2021

Link zum Volltext

Verfügbarkeit prüfen

Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A

Thrombosis and haemostasis, 2012-07, Vol.108 (1), p.21

2012

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system bleeding in patients with rare bleeding disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.34-38

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays

Thrombosis and haemostasis, 2021-01, Vol.121 (1), p.27

2021

Link zum Volltext

Verfügbarkeit prüfen

On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients

International journal of laboratory hematology, 2012-02, Vol.34 (1), p.35-40

2012

Link zum Volltext

Verfügbarkeit prüfen

Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A

Thrombosis research, 2019-01, Vol.173, p.1-3

2019

Link zum Volltext

Verfügbarkeit prüfen

Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity

Journal of thrombosis and haemostasis, 2012-09, Vol.10 (9), p.1938-1943

2012

Link zum Volltext

Verfügbarkeit prüfen

Minimal factor XIII activity level to prevent major spontaneous bleeds

Journal of thrombosis and haemostasis, 2017-09, Vol.15 (9), p.1728-1736

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Factor V Leiden, Factor V Cambridge, Factor II G20210A and Methylenetetrahydrofolate Reductase C677T Mutations in Healthy and Thrombophilic Serbian Populations

Acta haematologica, 2004-01, Vol.112 (4), p.227-229

2004

Link zum Volltext

Verfügbarkeit prüfen

Radiographic cephalometry analysis of condylar position after bimaxillary osteotomy in patients with mandibular prognathism

Vojnosanitetski pregled, 2016-04, Vol.73 (4), p.318-325

2016

Link zum Volltext

Verfügbarkeit prüfen

The correlation between overall haemostatic potential with bleeding severity in haemophilia A

HAEMOPHILIA, 2018, Vol.24, p.19

2018

Link zum Volltext

Verfügbarkeit prüfen

Does the intensity and quality of treatment and not only the factor viii level influence global hemostasis in patients with hemophilia a?

Thrombosis research, 2016-08, Vol.144, p.133-135

2016

Link zum Volltext

Verfügbarkeit prüfen

Indirect diagnosis of haemophilia B by multiplex PCR/RFLP

Clinical and laboratory haematology, 2005-04, Vol.27 (2), p.145-146

2005

Link zum Volltext

Verfügbarkeit prüfen

A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity

Haematologica (Roma), 2015-03, Vol.100 (3), p.e87-e89

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance

Thrombosis and haemostasis, 2000-10, Vol.84 (4), p.723

2000

Link zum Volltext

Verfügbarkeit prüfen

Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETP

Mediterranean journal of hematology and infectious diseases, 2017, Vol.9 (1), p.e2017064-e2017064

2017

Link zum Volltext

Verfügbarkeit prüfen

Does quality of treatment influence global hemostasis irrespectively of FVIII levels in patients with hemophilia A?

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, Vol.13, p.590

2015

Link zum Volltext

Verfügbarkeit prüfen

THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.P-T-449-P-T-449

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

Measurement and prevalence of circulating ADAMTS13‐specific immune complexes in autoimmune thrombotic thrombocytopenic purpura

Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura

Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand

Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?

Cholesterol homeostasis is dysregulated in women with preeclampsia

Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A

Central nervous system bleeding in patients with rare bleeding disorders

Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays

On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients

Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A

Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity

Minimal factor XIII activity level to prevent major spontaneous bleeds

Prevalence of Factor V Leiden, Factor V Cambridge, Factor II G20210A and Methylenetetrahydrofolate Reductase C677T Mutations in Healthy and Thrombophilic Serbian Populations

Radiographic cephalometry analysis of condylar position after bimaxillary osteotomy in patients with mandibular prognathism

The correlation between overall haemostatic potential with bleeding severity in haemophilia A

Does the intensity and quality of treatment and not only the factor viii level influence global hemostasis in patients with hemophilia a?

Indirect diagnosis of haemophilia B by multiplex PCR/RFLP

A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity

Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance

Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETP

Does quality of treatment influence global hemostasis irrespectively of FVIII levels in patients with hemophilia A?

THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY

Suchergebnisse filtern